Priority Date: 14.03.12 (US 201261610746P)

PROCESS FOR MAKING CGRP RECEPTOR ANTAGONISTS

  • Application ID: EP13760317
  • Status: GRANT OF PATENT INTENDED

Applicant

Technology company logo small
Technology Company

Attorneys

no operation time available
4 offices
Technology Company
no operation time available
7 offices
Technology Company
no operation time available
7 offices
Technology Company
no operation time available
4 offices
Technology Company

Specialization

This EP application has the IPC combination A01, A61, and C07. Merck Sharp & Dohme Ltd. and Merck & Co. Inc. are specialized in the combination A01, A61, and C07. We found, that Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Uexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB, Vereenigde Octrooibureaux NV (V.O.), Niizuma Wasner GmbH and 24 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 14.03.2012 - Priority Date (US 201261610746P)
  • 19.09.2013 - Publication A2 (WO2013138418)
  • 21.01.2015 - Publication A2 (EP2825044)